US2015211967A1PendingUtilityA1
Preparation of samples for analysis and sampling device therefor
Assignee: TRAJAN SCIENT AUSTRALIA PTY LTDPriority: Jan 29, 2014Filed: Jan 28, 2015Published: Jul 30, 2015
Est. expiryJan 29, 2034(~7.5 yrs left)· nominal 20-yr term from priority
B01L 3/0275G01N 1/10B01L 2200/0631G01N 1/405
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A sampling device comprising a body that defines a fluid flow path from an inlet opening, wherein the flow path includes a bed of a porous polymer monolith selected to adsorb bioparticles from a matrix drawn or dispensed through the inlet opening and the bed.
Claims
exact text as granted — not AI-modified1 . A sampling device comprising a body that defines a fluid flow path from an inlet opening, wherein the flow path includes a bed of a porous polymer monolith selected to adsorb bioparticles from a matrix drawn or dispensed through the inlet opening and the bed.
2 . A device according to claim 1 wherein said body is a tubular body and the bed is a plug of the porous polymer monolith that fills a cross-section of the flow path.
3 . A sampling device according to claim 2 wherein the bed is formed in situ by initiation of a polymerisation mixture within said body.
4 . A sampling device according to claim 3 wherein said initiation is by ultraviolet radiation.
5 . A sampling device according to claim 2 wherein the porous polymer monolith is a result of polymerisation of one or more monomers in the presence of two or more porogens.
6 . A sampling device according to claim 5 wherein the monomers are methacrylates and the porogens include an alcohol and an alkane.
7 . A sampling device according to claim 2 wherein the porous monomer monolith is selected to adsorb at least red blood cells from whole or buffered blood.
8 . A sampling device according to claim 7 wherein the porous polymer monolith is selected to additionally adsorb white blood cells and platelets from the whole or buffered blood whereby to obtain a cell-free plasma or plasma-like fraction.
9 . A sampling device according to claim 1 wherein the porous polymer monolith is a result of polymerisation of one or more monomers in the presence of two or more porogens.
10 . A sampling device according to claim 1 comprising a pipette tip.
11 . A sampling device according to claim 1 comprising a cartridge adapted for solid phase extraction (SPE).
12 . A method of preparing for analysis a matrix containing bioparticles, comprising:
drawing or dispensing a volume of the matrix along a flow path defined by a sampling body through a bed of porous polymer monolith in the flow path, which bed is of sufficient length along the flow path whereby the bed adsorbs the bioparticles and a sub-volume of the matrix substantially free of the bioparticles remains adjacent to the bioparticles in the sampling body; and recovering matrix from the sub-volume for analysis.
13 . A method according to claim 12 wherein said body is a tubular body and the bed is a plug of the porous polymer monolith that fills a cross-section of the flow path.
14 . A method according to claim 12 including forming the bed in situ by initiation of a polymerisation mixture within said body.
15 . A method according to claim 14 wherein said initiation is by ultraviolet radiation.
16 . A method according to claim 12 wherein the porous polymer monolith is a result of polymerisation of two or more monomers in the presence of two or more porogens.
17 . A method according to claim 16 wherein the monomers are methacrylates and the porogens include an alcohol and an alkane.
18 . A method according to claim 12 wherein the porous monomer monolith is selected to adsorb at least red blood cells from whole or buffered blood.
19 . A method according to claim 18 wherein the porous polymer monolith is selected to additionally adsorb white blood cells and platelets from the whole or buffered blood whereby to obtain a cell-free plasma or plasma-like fraction.
20 . A method according to claim 13 wherein the porous polymer monolith is a result of polymerisation of two or more monomers in the presence of two or more porogens.Join the waitlist — get patent alerts
Track US2015211967A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.